Can a 10-Session program help older adults with mental illness overcome negative beliefs about aging?
NCT ID NCT07690098
First seen Jul 08, 2026 · Last updated Aug 28, 2026 · Updated 2 times
Summary
This pilot study tests a 10-session group program called AgingUP, designed for adults aged 50 and older living with severe mental illness. The program uses cognitive-behavioral and self-compassion techniques to help participants challenge negative beliefs about aging and mental illness. Researchers will compare participants who take the program with those receiving usual care to see if it reduces self-ageism and self-stigma.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- AgingUP (Self-Ageism Reduction Program)
- What this could lead to
- If effective, this program could offer a new way to improve self-perception and quality of life for older adults with severe mental illness.
- What could go wrong
- This is a small pilot study with only 36 participants, so results may not apply broadly. The program may not produce lasting changes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
36 people
The number who actually took part.
- Started
-
Oct 2025
- Finished
-
Dec 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
50 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Age: ≥ 50 years (preventive/therapeutic focus on early and late aging in Severe Mental Illness). Diagnosis: Having a clinical diagnosis of Severe Mental Illness (SMI) such as schizophrenia, bipolar disorder, psychotic spectrum disorders, or severe affective disorders. Active Treatment: Currently receiving psychiatric or psychosocial treatment in a mental health center, rehabilitation unit, or community service. Legal Status: Not having a court-appointed legal representative. Voluntariness: Participation must be completely voluntary, without coercion or obligation. Language and Communication: Able to communicate in the language used for the study/intervention (e.g., Spanish). Availability: Willing to attend the scheduled sessions and activities according to the study/intervention design. Exclusion Criteria: * Severe Cognitive Impairment: Presence of advanced dementia or severe neurodegenerative disease that limits understanding or informed consent. Active Psychiatric Crisis: Experiencing an acute psychotic episode, manic crisis, or severe depression with high suicide risk at the time of assessment. Severe Medical Conditions: Having medical illnesses that prevent participation in study activities. Concurrent Study Participation: Participation in another ongoing study that may interfere with the objectives of this intervention. Legal Incapacity: Having a legal incapacity that prevents free and voluntary participation. Severe Cognitive Difficulties: Difficulties that significantly impair understanding of information or participation in group or digital activities. Language Barrier: Inability to understand the language in which the intervention is conducted, limiting comprehension of study content. Informed Consent: Failure to sign the informed consent form or expressing significant doubts about voluntary participation. Lack of Availability: Unwillingness or inability to attend the sessions according to the structure and duration of the study. Concurrent Participation: Participation in another study that could interfere with the goals of this intervention.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Mental disorder are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UNINPSI
Madrid, Madrid, 28036, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple screening help parents in child welfare get the mental health support they need?
- Could a diabetes drug curb opioid addiction? a trial puts semaglutide to the test
- Could a smartphone app help people on mental health waiting lists feel more prepared?
- Digital dream team: personalized advice may cut Long-Term sick leave
- Could better nutrition care transform recovery for older mental health patients?
- Could a single brain target treat depression, anxiety, and OCD at once?